Generic Name and Formulations:
Brinzolamide 1%; oph. susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for AZOPT:
Open-angle glaucoma. Ocular hypertension.
1 drop 3 times daily.
Carbonic anhydrase inhibitor (sulfonamide).
Hepatic impairment. Severe renal impairment (CrCl <30mL/min): not recommended. Discontinue if serious systemic, ocular (eg, conjunctivitis, lid edema), or hypersensitivity reactions occur. Soft contact lenses (remove; may reinsert 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers: not recommended.
Concomitant oral carbonic anhydrase inhibitors: not recommended. Separate administration of other oph drugs by ≥10 minutes.
Blurred vision, bitter/sour taste, blepharitis, dermatitis, dry eye, foreign body sensation, headache, hyperemia; ocular discharge, discomfort, or itch; keratitis, rhinitis.
Susp—2.5mL, 5mL, 10mL, 15mL
- 10ml of 1% eye droppers (Qty:1)
- appx. price $213.00
- Recall of Two IV Antibiotics Announced
- Five Things ID Experts Want You to Know Before You Prescribe an Antibiotic
- What's Changed in Immunization Recommendations From CDC Advisory Committee
- IUD Approval Gives Women New Long-Acting Birth Control Option
- Vitamin D: Greater Risk Factor for Diabetes Than Weight?
- Number of Docs, Retail Clinics Affect Antibiotic Prescribing Rate
- More Evidence Points to the Power of Nuts in Reducing CVD Mortality
- Overactive Bladder Drug May be Beneficial in MS
- FDA to Review Investigational Parkinson's Disease Drug Xadago
- How Prevalent is Antipsychotic Prescribing in Seniors with Dementia?